Cargando…
Anti-HMGCR Myopathy without Exposure to Statins: A Case Report
Anti-HMGCR, which was first identified in 2010, has emerged as an important mechanism of myopathogenesis in patients with exposure to statins. The availability of new detection methods has expanded the phenotypic spectrum with a subtype of population that hasn’t been exposed to the drug and whose cl...
Autores principales: | Ferriz Vivancos, Jorge, Sánchez, Marta Fandos, Timoneda, Pilar Teresa Timoneda, Benito, Goitzane Marcaida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768615/ https://www.ncbi.nlm.nih.gov/pubmed/36605298 |
Ejemplares similares
-
Utility of anti-GM-CSF antibodies in the diagnosis of pulmonary alveolar proteinosis: a case report
por: Sierra-Rivera, Antonio, et al.
Publicado: (2023) -
A Clinical Laboratory Study of a Non-Classical Case of Celiac Disease: How to Anticipate the Diagnosis
por: Raga, Ana Comes, et al.
Publicado: (2023) -
Anti-HMGCR Myopathy
por: Mohassel, Payam, et al.
Publicado: (2018) -
Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies: Inconstant Exposure to Statin
por: Allenbach, Yves, et al.
Publicado: (2014) -
Unusual Skin Involvement in Statin-induced Anti-HMGCR Immune-mediated Necrotizing Myopathy
por: SCARD, Camille, et al.
Publicado: (2021)